Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37,435,082
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
25,680,348
-
Shares change
-
-170,573
-
Total reported value, excl. options
-
$367,065,569
-
Value change
-
-$2,817,222
-
Number of buys
-
48
-
Number of sells
-
-28
-
Price
-
$14.4
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2018
99 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q3 2018.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,680,348 shares
of 37,435,082 outstanding shares and own 68.6% of the company stock.
Largest 10 shareholders include NWQ Investment Management Company, LLC (3,496,105 shares), FRANKLIN RESOURCES INC (2,715,500 shares), WYNNEFIELD CAPITAL INC (2,682,400 shares), DIMENSIONAL FUND ADVISORS LP (2,332,179 shares), BlackRock Inc. (2,002,544 shares), Vanguard Group Inc (1,535,517 shares), ROYCE & ASSOCIATES LP (1,393,764 shares), HEARTLAND ADVISORS INC (838,900 shares), Walthausen & Co., LLC (799,835 shares), and INVESTMENT COUNSELORS OF MARYLAND LLC (780,022 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.